JosephWoongKimMD

PubMed

• 15 citations
  Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
  Talal El Zarif, Amin H Nassar, Gregory R Pond, Tony Zibo Zhuang, Viraj Master
  Journal of the National Cancer Institute. 2023-12-06
• 17 citations
  Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984.
  Joseph W Kim, Rana R McKay, Marc R Radke, Shilin Zhao, Mary-Ellen Taplin
  Journal of Clinical Oncology. 2023-02-01
• 150 citations
  Prognostic and predictive roles of KRAS mutation in colorectal cancer.
  Amanda K. Arrington, Eileen L. Heinrich, Wendy Lee, Marjun P. Duldulao, Supriya S. Patel
  International Journal of Molecular Sciences. 2012-09-25

Journal Articles

• Transferable anticancer innate immunity in spontaneous regression/complete resistance mice  
  Hicks, A.M., Riedlinger, G., Willingham, M.C., Alexander-Miller, M.A., Von Kap-Herr, C., Pettenati, M.J., Sanders, A.M., Weir, H.M., Du, W., Kim, J., Simpson, A.J., Ol..., Proc Natl Acad Sci U.S.A., 1/16/2006

Books/Book Chapters

• Bethesda Handbook of Clinical Oncology 
  Chapter: Chapter 34: Hematopoietic Growth Factors. 
  Kim, J.W., Singh, N., and Arlen, P.Editors: J. Abraham, J.L. Gulley JL, and C.J. Allegra.Lippincott Williams & WilkinsEdition 4th,2014
• Principles of Molecular Diagnostics and Personalized Cancer Medicine 
  Chapter: Chapter 45: Vaccines and Cancer Therapy. 
  Page 594 - 609Kim, J.W., Gulley, J.L.Editors: D. Tan, and H. Lynch.Lippincott Williams & Wilkins, Philadelphia, PAEdition 1st,2013

Abstracts/Posters

• Single-agent LV305 to induce anti-tumor immune and clinical responses in patients with advanced or metastatic sarcoma and other cancers expressing NY-ESO-1.
  Neeta Somaiah, Matthew Stephen Block, Joseph W. Kim, Geoffrey Shapiro, Khanh Tu Do, Patrick Hwu, Joseph Paul Eder, Robin Lewis Jones, Sacha Gnjatic, Hailing Lu, Jan Te..., J Clin Oncol; ASCO Annual Meeting, 1/1/2016
• Efficacy and safety of nivolumab monotherapy in metastatic urothelial cancer (mUC): Results from the phase I/II CheckMate 032 study.
  Padmanee Sharma, Petri Bono, Joseph W. Kim, Pavlina Spiliopoulou, Emiliano Calvo, Rathi Narayana Pillai, Patrick Alexander Ott, Filippo G. De Braud, Michael A. Morse, ..., J Clin Oncol; ASCO Annual Meeting, 1/1/2016
• CheckMate-032: Phase I/II, open-label study of safety and activity of nivolumab (nivo) alone or with ipilimumab (ipi) in advanced and metastatic (A/M) gastric cancer (...
  Yelena Yuriy Janjigian, Johanna C. Bendell, Emiliano Calvo, Joseph W. Kim, Paolo Antonio Ascierto, Padmanee Sharma, Patrick Alexander Ott, Petri Bono, Dirk Jaeger, T.R..., J Clin Oncol; ASCO Annual Meeting, 1/1/2016
• Safety and activity of nivolumab monotherapy in advanced and metastatic (A/M) gastric or gastroesophageal junction cancer (GC/GEC): Results from the CheckMate-032 study.
  Dung T. Le, Johanna C. Bendell, Emiliano Calvo, Joseph W. Kim, Paolo Antonio Ascierto, Padmanee Sharma, Patrick Alexander Ott, Petri Bono, Dirk Jaeger, T.R. Jeffry Eva..., J Clin Oncol; GI Cancers Symposium, 1/1/2016
• Changes in T cell immunity in patients with metastatic castration resistant prostate treated with Radium-223 treatment.
  Joseph W. Kim, Youna Kang, Min Shin, Hari Anant Deshpande, Michael E. Hurwitz, John D. Roberts, Joseph G. Cardinale, Ashwatha Narayana, Insoo Kang, Daniel Peter Petrylak, J Clin Oncol; GU Cancers Symposium, 1/1/2016
• A phase Ia study of MPDL3280A (anti-PDL1): Updated response and survival data in urothelial bladder cancer (UBC).
  Daniel Peter Petrylak, Thomas Powles, Joaquim Bellmunt, Fadi S. Braiteh, Yohann Loriot, Cristina Cruz Zambrano, Howard A. Burris, Joseph W. Kim, Siew-leng Melinda Teng..., J Clin Oncol; ASCO Annual Meeting, 1/1/2015
• Phase I, first-in-human trial of LV305 in patients with advanced or metastatic cancer expressing NY-ESO-1.
  Neeta Somaiah, Matthew Stephen Block, Joseph W. Kim, Geoffrey Shapiro, Patrick Hwu, Joseph Paul Eder, Robin Lewis Jones, Sacha Gnjatic, Hailing Lu, Frank James Hsu, Se..., J Clin Oncol; ASCO Annual Meeting, 1/1/2015
• Clinical activity, safety, and biomarkers of MPDL3280A in metastatic urothelial bladder cancer: Additional analysis from phase IA study.
  Joseph W. Kim, Joaquim Bellmunt, Thomas Powles, Yohann Loriot, Nicholas J. Vogelzang, Cristina Cruz Zambrano, Howard A. Burris, Siew-leng Melinda Teng, Xiaodong Shen, ..., J Clin Oncol; GU Cancers Symposium, 1/1/2015
• Safety profile of poxviral vaccines: NCI experience.
  Joseph W. Kim, Jennifer L. Marte, Marijo Bilusic, Nishith K. Singh, Christopher Ryan Heery, Ravi Amrit Madan, Mary Pazdur, Sheri McMahon, Myrna Rauckhorst, Jeffrey Sch..., J Clin Oncol; Annual Meeting ASCO, 1/1/2013
• Safety profile of recombinant poxviral TRICOM vaccines.
  Joseph W. Kim, Jennifer L. Marte, Nishith K. Singh, Christopher Ryan Heery, Ravi Amrit Madan, Mary Pazdur, Sheri McMahon, Myrna Rauckhorst, Jeffrey Schlom, Philip W. K..., J Clin Oncol; Annual Meeting ASCO, 1/1/2013
• First-in-human phase I trial of NHS-IL12 in advanced solid tumors.
  Joseph W. Kim, Christopher Ryan Heery, Marijo Bilusic, Nishith K. Singh, Ravi A. Madan, Helen Sabzevari, Jeffrey Schlom, James L. Gulley, J Clin Oncol; Annual Meeting ASCO, 1/1/2012
• A pilot study on the clinical value of 18F-sodium fluoride PET/CT in advanced prostate cancer.
  Joseph W. Kim, Maria Liza Lindenberg, William L. Dahut, James L. Gulley, Ravi A. Madan, Lauren V. Wood, Yolanda McKinney, Peter L. Choyke, Karen A Kurdziel, Andrea Bor..., J Clin Oncol; Annual Meeting ASCO, 1/1/2012
• Join now to see all

Lectures

• Overcoming Resistance 
  Orlando, FL - 1/1/2015
• Overcoming Immune Suppression in Genitourinary Cancers 
  Philadelphia, PA - 1/1/2015
• Advanced Prostate Cancer and Treatment 
  John DeQuattro Cancer Center, Manchester, CT - 1/1/2014
• Combining Vaccine with Hormonal Therapy for Prostate Cancer 
  University of Chicago Comprehensive Cancer Center - 1/1/2013
• Join now to see all